Last quarter (Q4 2023), Blueprint Medicines's total revenue was $71.96M, a decrease of -5310.50% from the same quarter last year. In Q4, Blueprint Medicines's net income was $-110.92M. See Blueprint Medicines’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 231.69M	$ 249.38M	$ 204.04M	$ 180.08M	$ 793.74M	$ 66.51M
Cost of Revenue	$ 2.19M	$ 8.54M	$ -17.81M	$ -17.93M	$ 425.00K	$ 0.00
Gross Profit	$ 177.49M	$ 240.84M	$ -26.76M	$ -25.73M	$ 793.31M	$ 66.51M
Operating Expense	$ 722.86M	$ 722.86M	$ 714.79M	$ 796.33M	$ 484.60M	$ 427.84M
Operating Income	$ -543.64M	$ -477.76M	$ -741.55M	$ -822.06M	$ 308.71M	$ -361.33M
Net Non Operating Interest Income Expense	$ -12.97M	$ -18.79M	-	-	$ 6.60M	$ 13.73M
Other Income Expense	$ -62.34M	$ 946.00K	$ -206.04M	$ -178.59M	$ -366.00K	$ -100.00K
Pretax Income	$ -506.02M	$ -506.02M	$ -552.28M	$ -641.08M	$ 314.94M	$ -347.69M
Tax Provision	$ 968.00K	$ 968.00K	$ 5.24M	$ 3.00M	$ 1.06M	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -503.44M	$ -506.98M	$ -557.52M	$ -644.09M	$ 313.88M	$ -347.69M
Basic EPS	$ -8.36	$ -8.37	$ -9.35	$ -11.01	$ 5.76	$ -7.27
Diluted EPS	$ -8.36	$ -8.37	$ -9.35	$ -11.01	$ 5.59	$ -7.27
Basic Average Shares	$ 242.23M	$ 60.56M	$ 59.64M	$ 58.52M	$ 54.53M	$ 47.83M
Diluted Average Shares	$ 242.23M	$ 60.56M	$ 59.64M	$ 58.52M	$ 56.17M	$ 47.83M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 725.05M	$ 731.40M	$ 696.98M	$ 778.39M	$ 485.03M	$ 427.84M
Net Income From Continuing And Discontinued Operation	$ -506.98M	$ -506.98M	$ -557.52M	$ -644.09M	$ 313.88M	$ -347.69M
Normalized Income	$ -297.81M	$ -399.75M	-	-	$ 313.88M	$ -347.69M
Interest Expense	-	-	-	-	-	-
EBIT	$ -493.04M	$ -487.22M	$ -552.28M	$ -641.08M	$ 308.71M	$ -361.33M
EBITDA	$ -472.27M	$ -466.45M	$ -532.18M	$ -628.30M	$ 315.27M	$ -356.07M

Currency in USD

Blueprint Medicines Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing